Neuro-humoral regulation of lipolysis: Physiological and pathological aspects;Regulation neuro-humorale de la lipolyse: Aspects physiologiques et physiopathologiques

Medecine/Sciences

Volumn 14, Issue 8-9, 1998, Pages 865-876

  Lafontan, Max ^a   Langin, Dominique ^a  

^a CHU RANGUEIL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE CYCLASE; ADRENERGIC RECEPTOR; ALPHA 2 ADRENERGIC RECEPTOR; BETA 1 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR; CATECHOLAMINE DERIVATIVE; CYCLIC AMP DEPENDENT PROTEIN KINASE; DIACYLGLYCEROL; FATTY ACID; GLYCEROL; INSULIN; MONOACYLGLYCEROL; PHOSPHODIESTERASE; TRIACYLGLYCEROL; TRIACYLGLYCEROL LIPASE;

ADRENERGIC SYSTEM; AGE; BROWN ADIPOSE TISSUE; DIABETES MELLITUS; DIET; ENERGY BALANCE; ENZYME PHOSPHORYLATION; EXERCISE; FAMILIAL HYPERLIPEMIA; FATTY ACID METABOLISM; GENETIC ORGANIZATION; HORMONAL REGULATION; HYDROLYSIS; INSULIN RESISTANCE; LIPID METABOLISM; LIPOLYSIS; OBESITY; PATHOLOGY; PHYSIOLOGY; REVIEW; SEX; SUBCUTANEOUS TISSUE; TISSUE BLOOD FLOW; VISCERA; WHITE ADIPOSE TISSUE;

EID: 0031684044     PISSN: 07670974     EISSN: None     Source Type: Journal    
DOI: 10.4267/10608/1158     Document Type: Review

References (59)

1. Coppack SW, Jensen MD, Miles JM. In vivo regulation of lipolvsis in humans. J Lipid Res 1994; 35: 177-93.
2. Frayn KN, Williams CM, Arner P. Are increased plasma non-esterified fatty acid concentrations a risk marker for coronary heart diseases and other chronic diseases? Clin Sci 1996; 90: 243-53.
3. Boden G. Role of fatty acids in the pathogenesis of insulin resistance and NIDDM. Diabetes 1997; 46: 3-10.
4. Randle PJ, Garland PB, Hales CN, Newsholme EA. The glucose fatty-acid cycle: its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 1963; 1: 785-9.
5. Belfrage P, Fredrikson G, Stralfors P, Tornqvist H. 1984. Adipose tissue lipases. In : Borgström B, Brockman HL, eds. Lipases. Amsterdam, Elsevier, 1984.
6. Langin D, Holm C, Lafontan M. Adipocyte hormone-sensitive lipase : a major regulator of lipid metabolism. Proc Nutr Soc 1996; 55: 93-109.
7. Langin D, Laurell H, Holt LS, Belfrage P, Holm C. Gene organization and primary structure of human hormone-sensitive lipase: possible significance of a sequence homology with a lipase of Moraxella TA144, an antarctic bacterium. Proc Nalt Acad Sci USA 1993; 90: 4897-901.
8. Osterlund D, Danielsson B, Degerman E, Contreras JA, Edgren G, Davis RC, Schotz MC, Holm C. Domain-structure analysis of recombinant rat hormone-sensitive lipase. Biochem J 1996; 319: 411-20.
9. Contreras JA, Karlsson M, Osterlund T, Laurell H, Svensson A, Holm C. Hormone-sensitive lipase is structurally related to acetylcholinesterase, bile salt-stimulated lipase, and several fungal lipases. Building of a three-dimensional model for the catalytic domain of hormone-sensitive lipase. J Biol Chem 1996; 271: 31426-30.
10. Karlsson M, Contreras JA, Hellman U, Tornqvist H, Holm C, cDNA cloning, tissue distribution, and identification of the catalytic triad of monoglyceride lipase. Evolutionary relationship to esterases, lysophospholipases and haloperoxidases. J Biol Chem 1997; 272: 27218-33.
11. Anthonsen MW, Degerman E, Holm C. Partial purification and identification of hormone-sensitive lipase from chicken adipose tissue. Biochem Biophys Res Commun 1997; 236: 94-9.
12. Egan IJ, Greenberg AS, Chang MK, Wek SA, MC Moos J, Londos C. Mechanism of hormone-stimulated lipolysis in adipocytes: translocation of hormone-sensitive lipase to the lipid storage droplet. Proc Natl Acad Sci USA 1992; 89: 8537-41.
13. Blanchette-Mackie EJ, Dwyer NK, Barber T, Coxey RA, Takeda T, Rondinone CM, Theodorakis JL, Greenberg AS, Londos C. Perilipin is located on the surface layer of intracellular lipid droplets in adipocytes. J Lipid Res 1995; 30: 1211-26.
14. Hardie DG, Carling D. The AMP-activated protein-kinase. Fuel gauge of the mammalian cell? Eur J Biochem 1997; 246: 259-73.
15. Wood SL, Emmison N, Borthwick AC, Yeaman SJ. The protein phosphatases responsible for dephosphorylation of hormone-sensitive lipase in isolated rat adipocytes. Biochem J 1993; 295: 531-5.
16. Grober J, Laurell H, Blaise R, Fabry B, Schaak S, Holm C, Langin D. Characterization of the promoter of human adipocyte hormone-sensitive lipase. Biochem J 1997; 328: 453-61.
17. Laurell H, Grober J, Vindis C, Lacombe T, Dauzats M, Holm C, Langin D. Species-specific alternative splicing generates a catalytically inactive form of human hormone-sensitive lipase. Biochem J 1997; 328: 137-43.
18. Cummings DE, Brandon EP, Planas JV, Motamed K, Idzerda RJ, McKnight GS. Genetically lean mice result from targeted disruption of the RIIβ subunit of protein kinase A. Nature 1996; 382: 622-6.
19. Amieux PS, Cummings DE, Motamed K, Brandon EP, Wailes LA, Le K, Idzerda RL, McKnight GS. Compensatory regulation of RIalpha protein levels in protein kinase A mutant mice. J Biol Chem 1997; 272: 3993-8.
20. Degerman E, Belfrage P, Manganiello VC. Structure, localization, and regulation of cGMP-inhibited phosphodiesterase (PDE 3). J Biol Chem 1997; 272: 6823-6.
21. Wijkander J, Holst LS, Ralm T, Resjö S, Castan I, Manganiello V, Belfrage P, Degerman E. Regulation of protein kinase B in rat adipocytes by insulin, vanadate and peroxovanadate. Membrane translocation in response to peroxovanadate. J Biol Chem 1997; 272: 21520-6.
22. Wijkander J, Landström TR. Manganiello V, Belfrage P, Degerman E. Insulininduced phosphorylation and activation of phosphodiesterase 3B in rat adipocytes : Possible role for protein kinase B but not mitogen-activated protein kinase or p70S6 kinase. Endocrinology 1998; 139: 219-27.
23. Lafontan M, Berlan M. Fat cell adrenergic receptors and the control of white and brown fat cell function. J Lipid Res 1993; 34 : 1057-91.
24. Bockaert, J. Les réreptetirs à sept domaines transmembranaires : physiologie et pathologie de la transduction. Med Sci 1995; 11: 382-94.
25. Lafontan M. Differential recruitment and differential regulation by physiological amines of fat cell β1-, β2- and β3-adrenergic receptors expressed in native fat cells and transfected cell lines. Cell Signal 1994; 6: 363-92.
26. Tavernier G, Barbe P, Galitzky J, Berlan M, Caput D, Lafontan M, Langin D. Expression of β3-adrenoceptors with low lipolytic action in human subcutaneous fat cells. J Lipid Res 1996; 37: 87-97.
27. Strosberg DA, Manning BSJ. Le récepteur β3-adrénergique: un gène de poids. Med Sci 1995; 11: 1460-2.
28. Galitzky J, Langin D, Verwaerde P, Montastruc JL, Lafontan M, Berlan M, Lipolytic effects of conventional β3-adrenoceptor agonists and of CGP12,177 in rat and human fat cells: preliminary pharmacological evidence for a putative ́4-adrenoceptor. Br J Pharmacol 1997; 122: 1244-50.
29. Castan I, Valet P, Lafontan M. Le récepteur du PYY: un élément important du système antilipolytique de l'adipocyte. Med Sci 1994; 10: 196-201.
30. Lafontan M, Berlan M. Fat cell α2-adrenoceptors: the regulation of fat cell function and lipolysis. Endocrine Rev 1995; 16: 716-38.
31. Vassaux G, Gaillard D, Mari B, Ailhaud G, Negrel R. Differential expression of adenosine A1 and A2 receptors in preadipocytes and adipocytes. Biochem Biophys Res Commun 1993; 193: 1123-30.
32. Lafontan M, Arner P. Application of in situ microdialysis to measure metabolic and vascular responses in adipose tissue. Trends Pharmacol Sci 1996; 17: 309-13.
33. Raclot T, Langin D, Lafontan M. Groscolas R. Selective release of human adipocyte fatty acids according to molecular structure. Biochem J 1997; 324: 911-5.
34. Raclot T. Selective mobilization of fatty acids from white fat cells: evidence for a relationship to the polarity of triacylglycerols. Biochem J 1997; 322: 483-9.
35. Raclot T, Groscolas, R. Differential mobilization of white adipose tissue fatty acids according to chain length, unsaturation, and positional isomerism. J Lipid Res 199 3; 34: 1515-26.
36. Halliwell KJ. Fielding BA, Samra JS, Humphreys SM, Frayn KN. Release of individual fatty acids from human adipose tissue in vivo after an overnight fast. J Lipid Res 1996; 37: 1842-8.
37. Crandall DL, DiGirolamo M. Hemodynamic and metabolic correlates in adipose tissue: pathophysiologic considerations. FASEB J 1990; 4: 141-7.
38. Crandall DL. Haussman GJ, Kral JG. A review of the microcirculation of adipose tissue : anatomic, metabolic and angiogenic perspectives. Microcirculation 1997; 4: 211-32.
39. Linde B, Hjelmdahl P, Freyschuss U, Juhlin-Dannfelt A. Adipose tissue and skeletal muscle blood flow during mental stress. Am J Physiol 1981; 256: E12-8.
40. Enoksson S, Nordenström J, Bolinder J, Arner P. Influence of local blood flow on glycerol levels in human adipose tissue. Int J Obes 1995; 19: 350-4.
41. Galitzky J, Lafontan M, Nordenström J, Arner P. Role of vascular alpha2-adrenoceptors in regulating lipid mobilization from human adipose tissue. J Clin Invest 1993; 91 : 1997-2003.
42. Arner P, Bülow J. Assessment of adipose tissue metabolism in man : comparison of Fick and microdialysis techniques. Clin Sci 1993; 85: 247-56.
43. Arner P. Control of lipolysis and its relevance to development of obesity in man. Diabetes Metab Rev 1988; 4: 507-15.
44. Stich V, Harant I, Glisezinski ID, Crampes F, Berlan M, Kunesova M, et al. Adipose tissue lipolysis and hormone-sensitive lipase expression during very-low-calorie diet in obese female identical twins. J Clin Endocrinol Metab 1997; 82: 739-44.
45. Jansson PA, Larsson A, Smith U, Lönnroth P. Glycerol production in subcutaneous adipose tissue of lean and obese humans. J Clin Invest 1192; 89: 1610-7.
46. Reynisdottir S, Wahrenberg H, Carlström K, Rössner S, Arner P. Catecholamine resistance in fat cells of women with upper body obesity due to decreased expression of beta2-adrenoceptors. Diabetologia 1994; 37: 428-35.
47. Lönnqvist F, Wahrenberg H, Hellstrom L, Reynisdottir S, Arner P. Lipolytic catecholamine resistance due to decreased β2-adrenoceptor expression in fat cells. J Clin Invest 1992; 90: 2175-86.
48. Revnisdottir S, Ellerfeldt, Wahrenberg H, Lithell H, Arner P. Multiple lipolysis defects in the insulin resistance (metabolic) syndrome. J Clin Invest 1994; 93: 2590-9.
49. Mauriège P, Prud'homme D, Lemieux S, Tremblay A, Després JP. Regional differences in adipose tissue lipolysis from lean and obese women : existence of postreceptor alterations. Am J Physiol 1995; 269: E341-50.
50. Mauriège P, Marette A, Atgié C, Bouchard C, Thériault G, Bukowiecki LK, Marceau P, Biron S, Nadeau A, Després JP. Regional variation in adipose tissue metabolism of severely obese premenopausal women. J Lipid Res 1995; 36: 672-84.
51. Lönnqvist F, Nyberg B, Wahrenberg H, Arner P. Catecholamine-induced lipolysis in adipose tissue of the elderly. J Clin Invest 1990; 85: 1614-21.
52. Large V, Hellström L, Reynisdottir S, Lönnqvist F, Eriksson P, Lannfelt L, Arne P. Human beta2-adrenoceptor gene polymorphism are highly frequent in obesity and associated with altered adipocyte beta2-adrenoceptor function. J Clin Invest 1997; 100: 3005-13.
53. Bougnères P, Le Stunff C, Pecqueur C, Pinglier E, Adnot P, Ricquier D. In viva resistance of lipolysis to epinephrine. A new feature of childhood onset obesity. J Clin Invest 1997; 99: 2568-73.
54. Hellström L, Langin D, Reynisdottir S, Dauzats M, Arner P. Adipocyte lipolysis in normal weight subjects with obesity among first degree relatives. Diabetologia 1996; 39: 921-8.
55. Mauriège P, Després JP, Prud'homme D, Pouliot MC, Marcotte M, Tremblay A, Bouchard C. Regional variation in adipose tissue lipolysis in lean and obese men. J Lipid Res 1991; 32: 1625-33.
56. Kaartinen J, Hreniuk S, Martin LF, Ranta S, Lanoue KF, Ohisalo JJ. Attenuated adenosine sensitivity and decreased adenosine receptor number in adipocyte plasma membranes in human obesity. Biochem J 1991; 279: 17-22.
57. Kelley DE, Mokan M, Simonneau J-A, Mandarino LJ. Interaction between glucose and free fatty acid metabolism in human skeletal muscle. J Clin Invest 1993; 92: 91-8.
58. Boden G, Chen X, Ruiz J, White JV, Rossetti L. Mechanisms of fatty acid induced inhibition of glucose uptake. J Clin Invest 1994; 93: 2438-46.
59. Roden M, Price TB, Perseghin G, Patterson KF, Rothman DL, Cline GW, Shulman GI. Mechanism of free fatty-acid induced insulin resistance in humans. J Clin Invest 1996; 97: 2859-65.